M&A Deal Summary |
|
---|---|
Date | 2024-06-26 |
Target | Agile |
Sector | Medical Products |
Buyer(s) | Insud Pharma |
Deal Type | Add-on Acquisition |
Deal Value | 45M USD |
Advisor(s) | H. C. Wainwright & Co., LLC (Financial) Morgan Lewis (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Insud Pharma operates throughout the value chain of the pharmaceutical industry, offering specialized knowledge in scientific research, development, manufacturing, sale, and marketing of a wide range of active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), and pharmaceutical products of the brand for the care of humans and animals and biopharmaceuticals. Insud Pharma is based in Madrid, Spain.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (New Jersey) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2024) | 1 of 1 |
Size (of disclosed) | 1 of 1 |